Patent ID: 11866446
Assignee: VERTEX PHARMACEUTICALS INCORPORATED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 12:
13. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 1, wherein R5 is selected from C1-C4 alkyl, —C(═O)O(C1-C2 alkyl), C3-C6 cycloalkyl, and 5- to 10-membered heterocyclyl; wherein:
the C1-C4 alkyl of R5 is optionally substituted with 1 to 3 groups independently selected from halogen, cyano, —OH, and C1-C2 alkoxy; and
the C3-C6 cycloalkyl and the 5 to 10-membered heterocyclyl of R5 are each optionally substituted with 1 to 3 groups independently selected from halogen, cyano, —OH, C1-C2 alkyl, and C1-C2 alkoxy.